Pricing of HPV Vaccines in Europe: Back to the Future? Livio GarattiniAnna Padula Editorial 23 February 2018 Pages: 275 - 277
Policy Options for Infliximab Biosimilars in Inflammatory Bowel Disease Given Emerging Evidence for Switching Don HusereauBrian FeaganCarl Selya-Hammer Current Opinion Open access 06 February 2018 Pages: 279 - 288
Individual and Institutional Corruption in European and US Healthcare: Overview and Link of Various Corruption Typologies Margit Sommersguter-ReichmannClaudia WildAndrea Fried Review Article Open access 23 March 2018 Pages: 289 - 302
Economic Studies on Non-Communicable Diseases and Injuries in India: A Systematic Review Indrani GuptaArjun Roy Systematic Review 02 April 2018 Pages: 303 - 315
Long-Term Costs and Health Consequences of Issuing Shorter Duration Prescriptions for Patients with Chronic Health Conditions in the English NHS Adam MartinRupert PayneEdward CF Wilson Original Research Article 12 March 2018 Pages: 317 - 330
A Cost-Effectiveness Analysis of the 10-Valent Pneumococcal Non-Typeable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV) Compared to the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) for Universal Mass Vaccination Implementation in New Zealand Lijoy VargheseLouise TalbotBruce A. Mungall Original Research Article Open access 09 April 2018 Pages: 331 - 345
Spillover Effects of Long-Term Disabilities on Close Family Members Diana Pacheco Barzallo Original Research Article 12 April 2018 Pages: 347 - 355
Treating Type 1 Diabetes Mellitus with a Rapid-Acting Analog Insulin Regimen vs. Regular Human Insulin in Germany: A Long-Term Cost-Effectiveness Evaluation William J. ValentineKate Van BruntRichard F. Pollock Original Research Article 10 March 2018 Pages: 357 - 366
Out of Pocket Costs and Health Insurance Take-Up Rates Vasilios D. KosteasFrancesco Renna Original Research Article 12 April 2018 Pages: 367 - 380
Understanding Treatment Effect Estimates When Treatment Effects Are Heterogeneous for More Than One Outcome John M. BrooksCole G. ChapmanMary C. Schroeder Original Research Article 27 March 2018 Pages: 381 - 393
Is BRCA Mutation Testing Cost Effective for Early Stage Breast Cancer Patients Compared to Routine Clinical Surveillance? The Case of an Upper Middle-Income Country in Asia Ka Keat LimSook Yee YoonNathorn Chaiyakunapruk Original Research Article 23 March 2018 Pages: 395 - 406
Does €1 Per Prescription Make a Difference? Impact of a Capped Low-Intensity Pharmaceutical Co-Payment Pilar García-GómezToni MoraJaume Puig-Junoy Original Research Article 16 March 2018 Pages: 407 - 414
Cost-Consequence Analysis Alongside a Randomised Controlled Trial of Hospital Versus Telephone Follow-Up after Treatment for Endometrial Cancer Padraig DixonKinta BeaverWilliam Hollingworth Original Research Article Open access 12 April 2018 Pages: 415 - 427